Although alterations in NFκB or IκB genes are documented in some neoplasms, in other cases, dysfunctions in components of the NFκB/Rel-activating signaling pathways or influences of other mutated proteins on NFκB/Rel can be recognized [176]. The gene discussed is REL; the disease is neoplasm.